Number of patients treated by several lines of chemotherapy (≥2) was lower in patients with EATL and RCDII (26%) than in patients with EATL and gluten free diet-responsive CD or RCDI (56%), although the difference did not reach statistical significance.
← all excerpts
Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study.
1
—
—